OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 86 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 189.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $382,000 | -0.3% | 77,761 | +0.8% | 0.00% | – |
| Q3 2016 | $383,000 | -1.0% | 77,119 | +1.5% | 0.00% | – |
| Q2 2016 | $387,000 | -1.5% | 75,960 | +10.4% | 0.00% | -100.0% |
| Q1 2016 | $393,000 | -44.1% | 68,801 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $703,000 | -43.5% | 67,722 | +0.4% | 0.00% | -50.0% |
| Q3 2015 | $1,245,000 | -7.8% | 67,429 | -2.9% | 0.00% | 0.0% |
| Q2 2015 | $1,351,000 | +36.9% | 69,447 | +23.7% | 0.00% | +100.0% |
| Q1 2015 | $987,000 | +10.3% | 56,142 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $895,000 | +26.6% | 55,994 | -0.2% | 0.00% | 0.0% |
| Q3 2014 | $707,000 | -17.1% | 56,117 | +2.8% | 0.00% | 0.0% |
| Q2 2014 | $853,000 | +41.9% | 54,604 | +19.4% | 0.00% | 0.0% |
| Q1 2014 | $601,000 | -18.3% | 45,744 | -0.0% | 0.00% | 0.0% |
| Q4 2013 | $736,000 | -5.6% | 45,753 | -2.3% | 0.00% | 0.0% |
| Q3 2013 | $780,000 | +72.9% | 46,847 | +4.6% | 0.00% | 0.0% |
| Q2 2013 | $451,000 | – | 44,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|